Posted On: 10/29/2014 11:36:28 AM
Post# of 9129
The following article describes the challenges of detecting ebola early. It is focuses on PCR, but the fundamental issue applies to the N-Assay (V). It is critical to determine the sensitivity of a diagnostic test due to how ebola makes its way into the blood. The N-Assay's sensitivity for Ebola needs to be determined, but we have an idea from Dr. Faro's presentation that the N-Assay's sensitivity is far better than its competitors.
The upshot of the article is that PCR does NOT work to detect Ebola EARLY enough to be very helpful. It is implied that by the time PCR can be used to detect ebola, the patient is already symptomatic. And of course there are cost issues related to equipment and training. So...all these companies with PCR based tests that got FDA EUAs...I suppose the news was good for their share price.
http://www.npr.org/blogs/health/2014/10/28/35...arly?sc=tw
The upshot of the article is that PCR does NOT work to detect Ebola EARLY enough to be very helpful. It is implied that by the time PCR can be used to detect ebola, the patient is already symptomatic. And of course there are cost issues related to equipment and training. So...all these companies with PCR based tests that got FDA EUAs...I suppose the news was good for their share price.
http://www.npr.org/blogs/health/2014/10/28/35...arly?sc=tw
(0)
(0)Scroll down for more posts ▼
